Possibility of the use of oral long-acting tetracyclines in the treatment of lyme neuroborreliosis [8]

Clinical Infectious Diseases

Volumn 31, Issue 3, 2000, Pages 848-849

  De Maria, A ^a   Primavera, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; LONG ACTING DRUG; MINOCYCLINE; TETRACYCLINE DERIVATIVE;

BORRELIA BURGDORFERI; CENTRAL NERVOUS SYSTEM DISEASE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; LETTER; LYME DISEASE; NAIL DISEASE; NEUROSYPHILIS; PRIORITY JOURNAL; QUESTIONNAIRE; SKIN DISCOLORATION; TOOTH COLOR; TOOTH DISEASE; TREPONEMA PALLIDUM;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; BORRELIA BURGDORFERI GROUP; DOXYCYCLINE; HUMANS; LYME NEUROBORRELIOSIS; MINOCYCLINE;

EID: 0034456758     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/314012     Document Type: Letter

References (9)

1. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis
2. Minocycline versus doxycycline in the treatment of Lyme neuroborreliosis
3. Adverse effects of minocycline versus doxycycline in the treatment of Lyme neuroborreliosis
4. Minocycline for symptomatic neurosyphilis in patients allergic to penicillin
5. Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis
6. Tetracyclines, chloramphenicol, erythromycin and miscellaneous antibacterial agents
7. An epidemiologic study of Lyme disease in southern Sweden
8. Clinical approach to initial choice of antimicrobial therapy